Opko Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Opko Health
OPK Stock  USD 1.25  0.03  2.46%   
Analyzing historical trends in various income statement and balance sheet accounts from Opko Health's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Opko Health's valuation are summarized below:
Gross Profit
121.5 M
Profit Margin
(0.28)
Market Capitalization
968.4 M
Enterprise Value Revenue
1.4399
Revenue
642.1 M
There are currently one hundred twenty trending fundamental ratios for Opko Health that can be evaluated and compared over time across competitors. We recommend to check out Opko Health's recent fundamental drivers against the all of the trends between 2010 and 2026.

Opko Health Total Revenue

435.23 Million

Check Opko Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Opko Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 118.5 M, Interest Expense of 57.3 M or Total Revenue of 435.2 M, as well as many indicators such as Price To Sales Ratio of 1.56, Dividend Yield of 0.0011 or PTB Ratio of 0.82. Opko financial statements analysis is a perfect complement when working with Opko Health Valuation or Volatility modules.
  
Build AI portfolio with Opko Stock
Check out the analysis of Opko Health Correlation against competitors.
For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.

Opko Health Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets2.7 B2.5 B1.9 B
Slightly volatile
Other Current Liabilities66 M108.6 M97.4 M
Slightly volatile
Total Current Liabilities233.2 M222.1 M196.9 M
Slightly volatile
Total Stockholder Equity1.6 B1.6 B1.3 B
Slightly volatile
Property Plant And Equipment Net149.9 M142.8 M103 M
Slightly volatile
Accounts Payable27.1 M54.1 M46.8 M
Slightly volatile
Cash521.6 M496.7 M172.3 M
Slightly volatile
Non Current Assets Total1.9 B1.8 B1.5 B
Slightly volatile
Non Currrent Assets Other20.3 M21.3 M205.1 M
Pretty Stable
Cash And Short Term Investments521.6 M496.7 M172.3 M
Slightly volatile
Common Stock Shares Outstanding838 M798.1 M539.3 M
Slightly volatile
Liabilities And Stockholders Equity2.7 B2.5 B1.9 B
Slightly volatile
Other Stockholder Equity4.2 B4 B2.6 B
Slightly volatile
Total Liabilities1 B960 M602.9 M
Slightly volatile
Property Plant And Equipment Gross317.4 M302.3 M155.9 M
Slightly volatile
Total Current Assets799.5 M761.4 M398.3 M
Slightly volatile
Intangible Assets570.8 M933.4 M879.9 M
Slightly volatile
Non Current Liabilities Total774.8 M737.9 M406 M
Slightly volatile
Short and Long Term Debt Total609.1 M580.1 M243.6 M
Slightly volatile
Other Current Assets23.3 M24.5 M90.3 M
Very volatile
Short Term Debt17.9 M33.7 M23.8 M
Slightly volatile
Common Stock Total Equity8.3 M7.9 M5.6 M
Slightly volatile
Common Stock8.5 M8.1 M5.7 M
Slightly volatile
Other Liabilities142 M145.4 M152.8 M
Pretty Stable
Other Assets1.2 B1.1 B379 M
Slightly volatile
Property Plant Equipment149.7 M142.5 M102 M
Slightly volatile
Current Deferred Revenue28.2 M43.4 M29.6 M
Slightly volatile
Inventory43.5 M65.3 M48.6 M
Slightly volatile
Good Will430.6 M608.6 M474.9 M
Slightly volatile
Capital Surpluse2.5 B3.7 B2.4 B
Slightly volatile
Long Term Investments65.9 M62.8 M29.7 M
Slightly volatile
Non Current Liabilities Other9.8 M10.3 M224.7 M
Slightly volatile
Warrants19.5 M21.9 M24 M
Slightly volatile
Short and Long Term Debt21.1 M17.3 M17.1 M
Slightly volatile
Long Term Debt Total167.7 M303.5 M182.3 M
Slightly volatile
Capital Lease Obligations44.6 M77.3 M32.2 M
Slightly volatile
Net Invested Capital1.3 B1.6 B1.8 B
Slightly volatile
Net Working Capital566.3 M539.3 M175 M
Slightly volatile
Capital Stock7.7 M8.1 M6.6 M
Slightly volatile

Opko Health Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization118.5 M112.9 M69.7 M
Slightly volatile
Total Revenue435.2 M820.1 M698.9 M
Slightly volatile
Other Operating Expenses1 B995 M836.1 M
Slightly volatile
Cost Of Revenue280.2 M462.4 M460.2 M
Slightly volatile
Total Operating Expenses559.2 M532.6 M393.8 M
Slightly volatile
Selling General Administrative367.3 M349.9 M270.1 M
Slightly volatile
Research Development127 M121 M84.2 M
Slightly volatile
Selling And Marketing Expenses522.4 K587.7 K641.5 K
Slightly volatile
Discontinued Operations93.2 K98.1 K704.1 K
Slightly volatile
Preferred Stock And Other Adjustments359.1 K378 K751.5 K
Slightly volatile
Interest Income5.3 M7.6 M18.5 M
Slightly volatile
Reconciled Depreciation102 M112.9 M98.3 M
Very volatile

Opko Health Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow61.2 M110.3 M97.8 M
Slightly volatile
Depreciation118.5 M112.9 M69.7 M
Slightly volatile
End Period Cash Flow538.1 M512.5 M175 M
Slightly volatile
Stock Based Compensation15 M12.7 M15.4 M
Pretty Stable

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.561.6523.6948
Slightly volatile
Dividend Yield0.00110.00120.0013
Slightly volatile
PTB Ratio0.820.862.5428
Slightly volatile
Days Sales Outstanding15689.49138
Slightly volatile
Book Value Per Share1.181.772.2433
Very volatile
Stock Based Compensation To Revenue0.01690.01780.564
Slightly volatile
Capex To Depreciation0.280.290.3522
Slightly volatile
PB Ratio0.820.862.5428
Slightly volatile
EV To Sales1.671.7620.492
Slightly volatile
Inventory Turnover4.926.377.2894
Slightly volatile
Days Of Inventory On Hand56.3259.29798
Slightly volatile
Payables Turnover3.987.697.621
Slightly volatile
Sales General And Administrative To Revenue3.24.414.6044
Very volatile
Research And Ddevelopement To Revenue0.160.170.3034
Slightly volatile
Capex To Revenue0.03830.04030.0363
Slightly volatile
Cash Per Share0.50.720.345
Very volatile
Intangibles To Total Assets0.370.550.655
Very volatile
Current Ratio3.753.942.3802
Very volatile
Receivables Turnover3.544.224.3789
Slightly volatile
Shareholders Equity Per Share1.181.772.244
Very volatile
Debt To Equity0.40.420.1792
Slightly volatile
Capex Per Share0.02020.03240.0311
Slightly volatile
Revenue Per Share0.540.921.1284
Slightly volatile
Interest Debt Per Share0.750.720.3945
Slightly volatile
Debt To Assets0.220.210.1123
Slightly volatile
Graham Number1.341.511.6448
Slightly volatile
Operating Cycle141149884
Slightly volatile
Price Book Value Ratio0.820.862.5428
Slightly volatile
Company Equity Multiplier1.761.851.4796
Slightly volatile
Long Term Debt To Capitalization0.210.270.1401
Pretty Stable
Total Debt To Capitalization0.140.240.1318
Slightly volatile
Debt Equity Ratio0.40.420.1792
Slightly volatile
Quick Ratio3.423.62.1061
Very volatile
Net Income Per E B T4.854.621.5897
Slightly volatile
Cash Ratio2.442.571.3286
Pretty Stable
Cash Conversion Cycle81.8877.98178
Slightly volatile
Days Of Inventory Outstanding56.3259.29798
Slightly volatile
Days Of Sales Outstanding15689.49138
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.11.311.001
Very volatile
Price To Book Ratio0.820.862.5428
Slightly volatile
Fixed Asset Turnover5.425.176.4571
Slightly volatile
Debt Ratio0.220.210.1123
Slightly volatile
Price Sales Ratio1.561.6523.6948
Slightly volatile
Asset Turnover0.190.290.3084
Slightly volatile
Gross Profit Margin0.540.50.4595
Slightly volatile
Price Fair Value0.820.862.5428
Slightly volatile

Opko Health Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.9 B2.8 B2.3 B
Slightly volatile
Enterprise Value1.9 B2.9 B2.3 B
Slightly volatile

Opko Fundamental Market Drivers

Forward Price Earnings64.5161
Cash And Short Term Investments431.9 M

Opko Upcoming Events

22nd of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Opko Health Financial Statements

Opko Health investors utilize fundamental indicators, such as revenue or net income, to predict how Opko Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue43.4 M28.2 M
Total Revenue820.1 M435.2 M
Cost Of Revenue462.4 M280.2 M
Stock Based Compensation To Revenue 0.02  0.02 
Sales General And Administrative To Revenue 4.41  3.20 
Research And Ddevelopement To Revenue 0.17  0.16 
Capex To Revenue 0.04  0.04 
Revenue Per Share 0.92  0.54 
Ebit Per Revenue(0.19)(0.20)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Opko Health is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Opko Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Opko Health Stock. Highlighted below are key reports to facilitate an investment decision about Opko Health Stock:
How To Invest In Opko
Details
Is Opko Stock a good investment?
Details
What is Opko Health's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Opko Health Correlation against competitors.
For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. Anticipated expansion of Opko directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Opko Health assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth
(0.13)
Earnings Share
(0.24)
Revenue Per Share
0.881
Return On Assets
(0.06)
Return On Equity
(0.13)
The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
It's important to distinguish between Opko Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Opko Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Opko Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY